SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.
Project Number1U19AI166761-01
Contact PI/Project LeaderHUNG, CHIUNG-YU Other PIs
Awardee OrganizationUNIVERSITY OF TEXAS SAN ANTONIO
Description
Abstract Text
Summary (Overall)
San Antonio has a rich tradition of excellence in the field of Medical Mycology, including
Coccidioidomycosis, also referred to as Valley Fever. These infections affect hundreds of thousands of
healthy and immunocompromised individuals in the endemic areas of the arid Southwest U.S., with a
majority of cases in California and Arizona. There are very few drugs to treat these infections and no
vaccine is available. Growing levels of antibiotic resistance are a major concern, and the latest data on the
expansion of the geographical area of infection is very worrisome. To address these major shortcomings,
we propose the establishment of the San Antonio-based Coccidioidomycosis Collaborative Research
Center (SA-CCRC). The new Center will be a highly collaborative place for synergistic multi- and
interdisciplinary interactions by members of the Center, which include highly experienced investigators in
the field of Coccidioides research, as well as others with substantial knowledge and/or technical expertise
in other areas whose talents are being attracted to this field for the very first time. Overall, the SA-CCRC
creates an optimal cohesive infrastructure to support integrated research, leverages resources at each of
the participating sites and organizations, and also extends to the establishment of novel academic-
industrial partnerships. Our Center has a strong translational emphasis, being distinctively focused on the
development of antifungal drugs and vaccines against coccidioidomycosis. The center is anchored by an
administrative core which will serve a central hub for providing the necessary organizational, administrative
and financial oversight structure for the Center’s day-to-day operations. The overall objectives for the SA-
CCRC are: i) to advance basic, translational and clinical research in the field of Coccidioidomycosis via
investigator-driven research projects, ii) to adapt, develop and implement state of the art techniques to the
Coccidioidomycosis field of research in support of the three different projects and the coccidioidomycosis
community at large, and iii) to administer a Development and Research Program for pilot funding and
mentoring of junior investigators and those new to the field of coccidioidomycosis. Altogether, the proposed
SA-CCRC program will fill critical voids and will have a powerful and sustainable effect on the field of
coccidioidomycosis research.
Public Health Relevance Statement
Narrative (Overall)
We will establish the San Antonio-based Coccidioidomycosis Collaborative Research Center at
San Antonio (SA-CCRC). This Center includes three Research Projects to conduct basic,
translational and clinical research in the field of coccidioidomycosis, two technical Cores to bring
novel technologies to this field, and an Administrative core to coordinate all activities in this
program and support and mentor junior investigators and those who are new to the field of
coccidioidomycosis. The Center creates a cohesive infrastructure to support integrated and
highly synergistic research with a focus on development of antifungal drugs and vaccines
against coccidioidomycosis which are urgently needed.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
800189185
UEI
U44ZMVYU52U6
Project Start Date
01-January-2022
Project End Date
31-December-2026
Budget Start Date
01-January-2022
Budget End Date
31-December-2022
Project Funding Information for 2022
Total Funding
$1,357,000
Direct Costs
$1,045,598
Indirect Costs
$311,402
Year
Funding IC
FY Total Cost by IC
2022
National Institute of Allergy and Infectious Diseases
$1,357,000
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1U19AI166761-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U19AI166761-01
Patents
No Patents information available for 1U19AI166761-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U19AI166761-01
Clinical Studies
No Clinical Studies information available for 1U19AI166761-01
News and More
Related News Releases
No news release information available for 1U19AI166761-01
History
No Historical information available for 1U19AI166761-01
Similar Projects
No Similar Projects information available for 1U19AI166761-01